The Pain in Amputees Reduced by Administration of Diet Examination
PARADE
Low-Carbohydrate Diet to Reduce Pain and Increase Quality of Life in Amputees
1 other identifier
interventional
28
1 country
1
Brief Summary
Phantom limb pain (PLP) is defined as pain or discomfort in a missing limb following amputation, whereas residual limb pain (RLP) is often experienced as pain at the site of amputation. Unfortunately, PLP can affect as many as 80% of upper- or lower-extremity amputees, with 40-60% also experiencing RLP. There are many theories regarding the mechanisms underlying these types of pain, but effective treatments remain elusive .Amputation of a limb is often accompanied by a traumatic event that can be emotionally devastating. Consequently, studies have reported high levels of depression in this population, up to 80%. Other studies have reported elevated levels of depression (70%), suicidality (30%) and posttraumatic stress disorder (PTSD, 20%) with PTSD being highly correlated with PLP. Thus, it is critical that effective treatments be employed that address, not only the chronic pain, but the comorbid conditions as well. Diet interventions have been utilized as a non-pharmacological method to reduce pain and/or inflammation. We have shown that a low-carbohydrate diet (LCD) reduced pain independent of weight loss. Importantly, we observed a reduction in depressive symptomology and improved quality of life (QOL) following the LCD. Thus, it is reasonable to expect that the LCD may have beneficial effects of pain experience and also on measures of QOL. Phase 1: To characterize the dietary habits, pain severity and psychological well-being of the local amputee population. Hypotheses: We expect that the local population will show high prevalence of phantom limb pain (PLP) and/or residual limb pain (RLP). Self-report of depressive symptomology, poor-quality diet, will coincide with low QOL reports. Phase 2: To assess the feasibility and efficacy of a low-carbohydrate diet (LCD) to reduce pain and increase QOL in amputees. Hypotheses: All participants will complete the 6-week LCD. Compared to baseline, a 6-week LCD will reduce self-reports of pain and depressive symptoms. Overall QOL will improve over 6 weeks with concomitant improved mood and sleep.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2022
CompletedFirst Submitted
Initial submission to the registry
July 13, 2022
CompletedFirst Posted
Study publicly available on registry
July 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 28, 2023
CompletedAugust 30, 2023
August 1, 2023
1.2 years
July 13, 2022
August 28, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
BPI Pain Severity Change
BPI pain severity is an average score out of 10.
Baseline (week 0), immediately after the intervention (week 6)
BPI Pain Interference Change
BPI pain interference is an average score from 9 items out of 10.
Baseline (week 0), immediately after the intervention (week 6)
SF-36 overall score change
The Short Form 36 (SF-36) quality of life score is a 0-150 score with higher scores reflecting poorer quality of life. Scores in each of the 7 sections (general health, limitations, physical health, emotional health, social activities, pain and energy) are summed to provide an overall quality of life score. Change scores will be calculated.
Baseline (week 0), immediately after the intervention (week 6)
Secondary Outcomes (9)
NPQ score change
Baseline (week 0), immediately after the intervention (week 6)
CES-D score change
Baseline (week 0), immediately after the intervention (week 6)
PSQI change score
Baseline (week 0), immediately after the intervention (week 6)
NEADL change score
Baseline (week 0), immediately after the intervention (week 6)
PROMIS-57 domain change
Baseline (week 0), immediately after the intervention (week 6)
- +4 more secondary outcomes
Other Outcomes (1)
Weight change
Baseline (week 0), immediately after the intervention (week 6)
Study Arms (1)
Phase 2 Intervention
EXPERIMENTALLow-Carbohydrate Diet
Interventions
Using a meal delivery service and a list of prepared meals and recipes, foods/meals will be delivered to participants weekly to maintain daily net carbohydrate intake to less than 40 grams.
Eligibility Criteria
You may qualify if:
- Amputation at least 6 months prior
You may not qualify if:
- Inability to read/understand English
- Active infection at amputation site
- PLP/RLP for at least 6 months (\>4/10 on visual analogue scale)
- Amputation at least 6 months prior
- Inability to read/understand English
- Current infection at amputation site
- Unmedicated diabetes
- Unwillingness to follow prescribed diet
- Recent weight change (\>4 kg in past month)
- Currently on a prescribed diet or consuming less than 100 g of daily carbohydrates
- History of eating disorders or other psychiatric disorders requiring hospitalization within the past 6 months
- Digestive diseases
- Difficulty chewing or swallowing
- Reliance on others for meal preparation
- Uncontrolled cardiovascular or pulmonary disease
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 13, 2022
First Posted
July 15, 2022
Study Start
July 1, 2022
Primary Completion
August 28, 2023
Study Completion
August 28, 2023
Last Updated
August 30, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- For 5 years following final data analysis
- Access Criteria
- De-identified data can be made available on encrypted servers for researchers whose research plans do not overlap with the aims of the current project. Requests will be assessed by the PI and Co-Is as needed.
Following our extended analysis period, de-identified data will be made available, as well as the variable key, to the scientific community. Before this time, a request for data sharing will be assessed by study personnel (PI and Co-Is) as needed. These requests will be evaluated based on scientific merit and overlap with the aims of the current study.